Bio-Rad Laboratories Class B
BIO.B
10 hedge funds and large institutions have $70.6M invested in Bio-Rad Laboratories Class B in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
583% more capital invested
Capital invested by funds: $10.3M → $70.6M (+$60.3M)
1.81% more ownership
Funds ownership: 0.35% → 2.16% (+1.8%)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tikvah Management
Charlotte,
North Carolina
|
+$59.7M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$23.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
-$3.43M |
| 2 |
SF
Synovus Financial
Columbus,
Georgia
|
-$465K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.89K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$607 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TM
1
Tikvah Management
Charlotte,
North Carolina
| $63.4M | +$59.7M | +98,357 | New |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $4.75M | – | – | – |
|
3
Renaissance Technologies
New York
| $1.47M | – | – | – |
|
4
Morgan Stanley
New York
| $443K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $289K | -$607 | -1 | -0.2% |
|
|
GAM
6
Gemmer Asset Management
Walnut Creek,
California
| $179K | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $36K | – | – | – |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $33K | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| $24K | +$23.1K | +38 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| $17K | -$7.89K | -13 | -33% |
|
|
11
Royal London Asset Management
United Kingdom
| – | -$3.43M | -5,927 | Closed |
|
|
SF
12
Synovus Financial
Columbus,
Georgia
| – | -$465K | -801 | Closed |
|
BIO.B Hedge Fund Activity: Q2 2021 in Review
10 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2021, worth a combined $70.6M — up 583% from $10.3M a quarter earlier.
Fund positioning in BIO.B was balanced in Q2 2021: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Tikvah Management, opening a new position worth an estimated $59.7M. The largest seller was Royal London Asset Management, exiting entirely with an estimated $3.43M sold.
- 10 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $70.6M of Bio-Rad Laboratories Class B stock for Q2 2021, up 583% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q2 2021 and 2 closed out, a net change of 0 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2021 was Tikvah Management, an estimated $59.7M added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2021 was Royal London Asset Management, an estimated $3.43M sold.
Based on aggregated 13F filings for Q2 2021.